635 related articles for article (PubMed ID: 22863620)
21. Mobilisation of the splenic monocyte reservoir and peripheral CX₃CR1 deficiency adversely affects recovery from spinal cord injury.
Blomster LV; Brennan FH; Lao HW; Harle DW; Harvey AR; Ruitenberg MJ
Exp Neurol; 2013 Sep; 247():226-40. PubMed ID: 23664962
[TBL] [Abstract][Full Text] [Related]
22. Erythropoietin modulates the immune-inflammatory response of a SOD1(G93A) transgenic mouse model of amyotrophic lateral sclerosis (ALS).
Noh MY; Cho KA; Kim H; Kim SM; Kim SH
Neurosci Lett; 2014 Jun; 574():53-8. PubMed ID: 24820540
[TBL] [Abstract][Full Text] [Related]
23. Brca1 is expressed in human microglia and is dysregulated in human and animal model of ALS.
Noristani HN; Sabourin JC; Gerber YN; Teigell M; Sommacal A; Vivanco Md; Weber M; Perrin FE
Mol Neurodegener; 2015 Aug; 10():34. PubMed ID: 26227626
[TBL] [Abstract][Full Text] [Related]
24. Effects of the PPARgamma activator pioglitazone on p38 MAP kinase and IkappaBalpha in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis.
Shibata N; Kawaguchi-Niida M; Yamamoto T; Toi S; Hirano A; Kobayashi M
Neuropathology; 2008 Aug; 28(4):387-98. PubMed ID: 18312546
[TBL] [Abstract][Full Text] [Related]
25. Origin and distribution of bone marrow-derived cells in the central nervous system in a mouse model of amyotrophic lateral sclerosis.
Solomon JN; Lewis CA; Ajami B; Corbel SY; Rossi FM; Krieger C
Glia; 2006 May; 53(7):744-53. PubMed ID: 16518833
[TBL] [Abstract][Full Text] [Related]
26. T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS.
Chiu IM; Chen A; Zheng Y; Kosaras B; Tsiftsoglou SA; Vartanian TK; Brown RH; Carroll MC
Proc Natl Acad Sci U S A; 2008 Nov; 105(46):17913-8. PubMed ID: 18997009
[TBL] [Abstract][Full Text] [Related]
27. Immunization with a Myelin-Derived Antigen Activates the Brain's Choroid Plexus for Recruitment of Immunoregulatory Cells to the CNS and Attenuates Disease Progression in a Mouse Model of ALS.
Kunis G; Baruch K; Miller O; Schwartz M
J Neurosci; 2015 Apr; 35(16):6381-93. PubMed ID: 25904790
[TBL] [Abstract][Full Text] [Related]
28. Deleterious effects of lymphocytes at the early stage of neurodegeneration in an animal model of amyotrophic lateral sclerosis.
Tada S; Okuno T; Yasui T; Nakatsuji Y; Sugimoto T; Kikutani H; Sakoda S
J Neuroinflammation; 2011 Feb; 8():19. PubMed ID: 21345177
[TBL] [Abstract][Full Text] [Related]
29. CCR2+ Ly6C(hi) inflammatory monocyte recruitment exacerbates acute disability following intracerebral hemorrhage.
Hammond MD; Taylor RA; Mullen MT; Ai Y; Aguila HL; Mack M; Kasner SE; McCullough LD; Sansing LH
J Neurosci; 2014 Mar; 34(11):3901-9. PubMed ID: 24623768
[TBL] [Abstract][Full Text] [Related]
30. Appearance of phagocytic microglia adjacent to motoneurons in spinal cord tissue from a presymptomatic transgenic rat model of amyotrophic lateral sclerosis.
Sanagi T; Yuasa S; Nakamura Y; Suzuki E; Aoki M; Warita H; Itoyama Y; Uchino S; Kohsaka S; Ohsawa K
J Neurosci Res; 2010 Sep; 88(12):2736-46. PubMed ID: 20648658
[TBL] [Abstract][Full Text] [Related]
31. Aberrant neuregulin 1 signaling in amyotrophic lateral sclerosis.
Song F; Chiang P; Wang J; Ravits J; Loeb JA
J Neuropathol Exp Neurol; 2012 Feb; 71(2):104-15. PubMed ID: 22249457
[TBL] [Abstract][Full Text] [Related]
32. The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS.
Henkel JS; Beers DR; Siklós L; Appel SH
Mol Cell Neurosci; 2006 Mar; 31(3):427-37. PubMed ID: 16337133
[TBL] [Abstract][Full Text] [Related]
33. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
34. A Novel Anti-Inflammatory d-Peptide Inhibits Disease Phenotype Progression in an ALS Mouse Model.
Post J; Kogel V; Schaffrath A; Lohmann P; Shah NJ; Langen KJ; Willbold D; Willuweit A; Kutzsche J
Molecules; 2021 Mar; 26(6):. PubMed ID: 33805709
[TBL] [Abstract][Full Text] [Related]
35. In Vivo imaging reveals distinct inflammatory activity of CNS microglia versus PNS macrophages in a mouse model for ALS.
Dibaj P; Steffens H; Zschüntzsch J; Nadrigny F; Schomburg ED; Kirchhoff F; Neusch C
PLoS One; 2011 Mar; 6(3):e17910. PubMed ID: 21437247
[TBL] [Abstract][Full Text] [Related]
36. A system mathematical model of a cell-cell communication network in amyotrophic lateral sclerosis.
Shao H; He Y; Li KC; Zhou X
Mol Biosyst; 2013 Mar; 9(3):398-406. PubMed ID: 23287963
[TBL] [Abstract][Full Text] [Related]
37. Actions of the antihistaminergic clemastine on presymptomatic SOD1-G93A mice ameliorate ALS disease progression.
Apolloni S; Fabbrizio P; Amadio S; Volonté C
J Neuroinflammation; 2016 Aug; 13(1):191. PubMed ID: 27549088
[TBL] [Abstract][Full Text] [Related]
38. Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Almer G; Vukosavic S; Romero N; Przedborski S
J Neurochem; 1999 Jun; 72(6):2415-25. PubMed ID: 10349851
[TBL] [Abstract][Full Text] [Related]
39. Accessory respiratory muscles enhance ventilation in ALS model mice and are activated by excitatory V2a neurons.
Romer SH; Seedle K; Turner SM; Li J; Baccei ML; Crone SA
Exp Neurol; 2017 Jan; 287(Pt 2):192-204. PubMed ID: 27456268
[TBL] [Abstract][Full Text] [Related]
40. Transformation from a neuroprotective to a neurotoxic microglial phenotype in a mouse model of ALS.
Liao B; Zhao W; Beers DR; Henkel JS; Appel SH
Exp Neurol; 2012 Sep; 237(1):147-52. PubMed ID: 22735487
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
